About Akari Therapeutics plc ADR (0.01 USD)
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
Market Cap
$0.03B
Employees
12
Listed Since
December 7, 2012
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.akaritx.comPhone
(646) 350-0702
Headquarters
22 BOSTON WHARF ROAD
BOSTON, MA 02210
CIK
0001541157